Mohammed Ghallab
Overview
Explore the profile of Mohammed Ghallab including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
195
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Acidi B, Faron M, Mir O, Levy A, Ghallab M, Kasraoui I, et al.
J Visc Surg
. 2025 Feb;
PMID: 40000299
Introduction: Surgery is the cornerstone treatment for retroperitoneal sarcomas (RPS). However, contraindications for unresectability are not well-documented in the literature. Aim Of The Study: This study aims to identify contraindications...
2.
Saleh M, Pascual F, Ghallab M, Wu A, Chin K, Ratti F, et al.
Ann Surg Oncol
. 2024 Jun;
31(9):5615-5630.
PMID: 38879668
Introduction: Despite the increasing widespread adoption and experience in minimally invasive liver resections (MILR), open conversion occurs not uncommonly even with minor resections and as been reported to be associated...
3.
Sousa Da Silva R, Breuer E, Shankar S, Kawakatsu S, Holowko W, Coelho J, et al.
Ann Surg
. 2023 Jul;
278(5):748-755.
PMID: 37465950
Objective: This study aims at establishing benchmark values for best achievable outcomes following open major anatomic hepatectomy for liver tumors of all dignities. Background: Outcomes after open major hepatectomies vary...
4.
Mabilia A, Mazzotta A, Robin F, Ghallab M, Vibert E, Adam R, et al.
Cancers (Basel)
. 2022 Oct;
14(20).
PMID: 36291934
: to date, long-term outcomes of R1 vascular (R1vasc) and R1 parenchymal (R1par) resections in the setting of intrahepatic cholangiocarcinoma (iCCA) have been examined in only one study which did...
5.
Tortajada P, Doamba R, Cano L, Ghallab M, Allard M, Ciacio O, et al.
Surgery
. 2022 Oct;
172(6):1704-1711.
PMID: 36241470
Background: Liver resection is a curative treatment for hepatocellular carcinoma (HCC) and an alternative to liver transplantation (LT). However, post-liver resection recurrence rates remain high. This study aimed to determine...
6.
Marques F, Ghallab M, Vibert E, Boleslawski E, Soubrane O, Adam R, et al.
HPB (Oxford)
. 2021 Nov;
24(6):848-856.
PMID: 34785122
Background: HCC are known to have satellite nodules and microvascular invasions requiring sufficient margins. An alpha-fetoprotein (AFP) level >100 ng/mL is associated with worse pathological features in HCC. In practice,...
7.
Davies S, Ghallab M, Hajibandeh S, Hajibandeh S, Addison S
Langenbecks Arch Surg
. 2020 Jun;
405(5):563-572.
PMID: 32572555
Objectives: To evaluate the comparative outcomes of three-dimensional (3D) versus two-dimensional (2D) imaging during laparoscopic cholecystectomy. Methods: We conducted a systematic search of electronic information sources and bibliographic reference lists...
8.
Tinti F, Mitterhofer A, Umbro I, Nightingale P, Inston N, Ghallab M, et al.
Transpl Int
. 2019 Feb;
32(9):918-932.
PMID: 30793378
Patient selection for combined liver-kidney transplantation (CLKT) is a current issue on the background of organ shortage. This study aimed to compare outcomes and post-transplant renal function for patients receiving...
9.
Coleman S, Watt J, Arumugam P, Solaini L, Carapuca E, Ghallab M, et al.
World J Gastroenterol
. 2014 Jul;
20(26):8471-81.
PMID: 25024603
Pancreatic cancer carries a terrible prognosis, as the fourth most common cause of cancer death in the Western world. There is clearly a need for new therapies to treat this...
10.
Coleman S, Chioni A, Ghallab M, Anderson R, Lemoine N, Kocher H, et al.
EMBO Mol Med
. 2014 Feb;
6(4):467-81.
PMID: 24503018
Pancreatic cancer is characterised by desmoplasia, driven by activated pancreatic stellate cells (PSCs). Over-expression of FGFs and their receptors is a feature of pancreatic cancer and correlates with poor prognosis,...